Loy H, Kuok DIT, Hui KPY, Choi MHL, Yuen W. Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A/H5N1-associated acute lung injury. J Infect Dis. 2018 Aug 2.
Background:
Highly pathogenic avian influenza viruses can cause severe forms of acute lung injury (ALI) in humans, where pulmonary flooding leads to respiratory failure. Therapeutic benefits of bone-marrow mesenchymal stromal cells (BM-MSCs) have been demonstrated in an influenza H5N1 ALI model. However, clinical translation is impractical and limited by declining efficacy with increase in donor age. Umbilical cord MSCs (UC-MSCs) are easier to obtain in comparison, and their primitive source may offer more potent therapeutic effects.
Methods:
Here we investigate the therapeutic efficacy of UC-MSCs on mechanisms of pulmonary oedema formation; alveolar fluid clearance (AFC) and protein permeability (APP), of H5N1-infected human alveolar epithelial cells (AECs). UC-MSCs were also tested in a mouse model of influenza ALI.
Results:
We found that UC-MSCs were effective in restoring impaired AFC and APP of H5N1-infected AECs. UC-MSCs consistently outperformed BM-MSCs, partly due to greater growth factor secretion of angiopoietin-1 and hepatocyte growth factor. Conditioned UC-MSC medium and UC-MSC exosomes were also able to recapitulate these effects. However, UC-MSCs only slightly improved survival of H5N1-infected mice.
Conclusions:
Our results suggest that UC-MSCs are effective in restoring AFC and APP in H5N1-associated ALI and confer functional in addition to practical advantages over conventional BM-MSCs.
Highly pathogenic avian influenza viruses can cause severe forms of acute lung injury (ALI) in humans, where pulmonary flooding leads to respiratory failure. Therapeutic benefits of bone-marrow mesenchymal stromal cells (BM-MSCs) have been demonstrated in an influenza H5N1 ALI model. However, clinical translation is impractical and limited by declining efficacy with increase in donor age. Umbilical cord MSCs (UC-MSCs) are easier to obtain in comparison, and their primitive source may offer more potent therapeutic effects.
Methods:
Here we investigate the therapeutic efficacy of UC-MSCs on mechanisms of pulmonary oedema formation; alveolar fluid clearance (AFC) and protein permeability (APP), of H5N1-infected human alveolar epithelial cells (AECs). UC-MSCs were also tested in a mouse model of influenza ALI.
Results:
We found that UC-MSCs were effective in restoring impaired AFC and APP of H5N1-infected AECs. UC-MSCs consistently outperformed BM-MSCs, partly due to greater growth factor secretion of angiopoietin-1 and hepatocyte growth factor. Conditioned UC-MSC medium and UC-MSC exosomes were also able to recapitulate these effects. However, UC-MSCs only slightly improved survival of H5N1-infected mice.
Conclusions:
Our results suggest that UC-MSCs are effective in restoring AFC and APP in H5N1-associated ALI and confer functional in addition to practical advantages over conventional BM-MSCs.
See Also:
Latest articles in those days:
- The evolution and transmission dynamics of H3N2 influenza virus identified in a respiratory disease outbreak in companion dogs in Alabama, USA 9 hours ago
- Structural and functional characterization of hemagglutinin E190D and Q226H minor variants in human H5N1 A/British Columbia/PHL-2032/2024 9 hours ago
- Spatial risk factors associated with outbreaks of highly pathogenic avian influenza in Pennsylvania’s commercial poultry farms 10 hours ago
- [preprint]H9N2 avian influenza virus in Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved antigenic phenotype 10 hours ago
- [preprint]Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication 10 hours ago
[Go Top] [Close Window]


